I am new to posting but read regularly. I own ATHX and wanted to make note of news that I came across today. Headline reads Athersys receives MHRA approval to expand Phase II ischemic stroke study. In short , the approval enables the company to bring several leading UK stroke centers into the study, which will help speed up the completion of the stroke clinical trial said Dr. Gil Van Bokkelen. "The authorization is also noteworthy as it marks the initiation of MultiStem clinical development in the UK." The source for this article is Datamonitor via Comtex.
no problem, this is a board to voice opinions, any good/bad news need to be shared new or not, upon much research I bought several hundred shares of ATHX and plan to add more below $2. also own GALE and adding below $2
OLD NEWS, been out for over a week. Try to find something new versus this irrelevant BS that has already been accounted for. When you have something new, post, until then, let's not recycle things that have already been discussed. Seriously.
Seriously? Why is it so necessary for you to be so condensing? It may be that some here have not heard this past new, ( I think the news is of great). What's the harm of you wasting 15 seconds of read time or 3 minute, not sure of your read time capacity? Your time can't be that valuable, since you are at a Y/M board! Long, here's to our future!